Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_assertion type Assertion NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_head.
- NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_assertion description "[The results of this study demonstrated that co-blockade of the major histocompatibility complex class (MHC)II:T cell receptor (TCR) and CD28:B7 pathways by using tetravalent human LAG3-Ig and CTLA4-Ig synergistically prevented murine acute GVHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_provenance.
- NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_assertion evidence source_evidence_literature NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_provenance.
- NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_assertion SIO_000772 22713982 NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_provenance.
- NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_assertion wasDerivedFrom befree-20140225 NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_provenance.
- NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_assertion wasGeneratedBy ECO_0000203 NP278255.RAefN4pTojiJCySl4JXLMWgYyXrumXrfrmyM-wbyhPAeE130_provenance.